Genomic Biomarkers to Improve Ulcerative Colitis Neoplasia Surveillance

No adequate means exist to identify the minority of ulcerative colitis (UC) patients destined to undergo neoplastic progression. Recognition of this subset would advance UC cancer surveillance by focusing the available management options onto the highest risk patients. Three different assays of geno...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bronner, Mary P., O'Sullivan, Jacintha N., Rabinovitch, Peter S., Crispin, David A., Chen, Lu, Emond, Mary J., Rubin, Cyrus E., Brentnall, Teresa A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Investigative Pathology 2008
Aiheet:
Regular Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626395/
https://ncbi.nlm.nih.gov/pubmed/18988798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2008.080250
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia